Header Logo

John Zajecka

Concepts (159)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Depressive Disorder, Major
18
2022
55
2.970
Why?
Antidepressive Agents
15
2022
48
1.900
Why?
Depressive Disorder
14
2003
90
1.180
Why?
Psychiatric Status Rating Scales
17
2020
132
0.750
Why?
Tetrahydrofolates
3
2016
3
0.680
Why?
Antidepressive Agents, Second-Generation
6
2010
11
0.570
Why?
Treatment Outcome
21
2022
1478
0.530
Why?
Double-Blind Method
15
2016
166
0.470
Why?
Secondary Prevention
9
2020
25
0.450
Why?
Humans
39
2022
12240
0.430
Why?
Fluoxetine
6
2005
13
0.410
Why?
Triazoles
3
2002
14
0.380
Why?
Substance Withdrawal Syndrome
3
1997
20
0.370
Why?
Depression
2
2022
229
0.370
Why?
Folic Acid
1
2011
15
0.340
Why?
Cyclohexanols
5
2010
9
0.340
Why?
Bipolar Disorder
5
2007
47
0.330
Why?
Adult
21
2016
3557
0.320
Why?
Acetamides
1
2010
2
0.310
Why?
Male
26
2020
6815
0.310
Why?
Female
25
2020
6974
0.300
Why?
Drug Therapy, Combination
5
2016
76
0.270
Why?
Middle Aged
14
2020
4043
0.270
Why?
Dose-Response Relationship, Drug
7
2015
179
0.260
Why?
Drug Administration Schedule
11
2007
84
0.250
Why?
Piperazines
5
2015
41
0.240
Why?
Surveys and Questionnaires
4
2015
546
0.200
Why?
Aged
10
2016
4000
0.200
Why?
Young Adult
4
2016
863
0.200
Why?
Personality Inventory
2
2000
31
0.190
Why?
Vagus Nerve Stimulation
1
2022
4
0.180
Why?
Obsessive-Compulsive Disorder
3
2006
11
0.180
Why?
Remission Induction
4
2020
45
0.180
Why?
Adolescent
7
2015
989
0.170
Why?
Acute Disease
4
2013
90
0.170
Why?
Anxiety Disorders
2
2002
84
0.160
Why?
Sertraline
3
2006
9
0.160
Why?
Recurrence
2
2016
126
0.150
Why?
Quality of Life
3
2010
261
0.140
Why?
Long-Term Care
2
2016
24
0.140
Why?
Antipsychotic Agents
3
2003
29
0.140
Why?
Randomized Controlled Trials as Topic
2
2011
128
0.130
Why?
Venlafaxine Hydrochloride
5
2010
8
0.120
Why?
Serotonin
2
1997
14
0.110
Why?
Combined Modality Therapy
4
2020
143
0.110
Why?
Placebos
4
2006
25
0.110
Why?
Sexual Dysfunction, Physiological
2
2007
4
0.110
Why?
Sulfides
1
2015
4
0.110
Why?
Anti-Anxiety Agents
1
2015
15
0.110
Why?
Patient Compliance
4
2007
75
0.110
Why?
S-Adenosylhomocysteine
1
2014
1
0.110
Why?
Aldehydes
1
2014
2
0.110
Why?
S-Adenosylmethionine
1
2014
3
0.110
Why?
Depressive Disorder, Treatment-Resistant
1
2014
3
0.110
Why?
Diagnosis, Differential
2
2007
151
0.110
Why?
C-Reactive Protein
1
2014
54
0.100
Why?
Vagus Nerve
2
2022
9
0.100
Why?
Prospective Studies
1
2016
817
0.100
Why?
Pirenzepine
2
2003
3
0.100
Why?
Valproic Acid
2
2003
7
0.100
Why?
Anticonvulsants
2
2003
30
0.100
Why?
Prevalence
1
2013
175
0.090
Why?
Antidepressive Agents, Tricyclic
2
2004
8
0.090
Why?
Multicenter Studies as Topic
1
2011
17
0.090
Why?
Cognition Disorders
1
2015
437
0.090
Why?
Sexual Dysfunctions, Psychological
1
1991
4
0.080
Why?
Patient Education as Topic
2
2003
64
0.080
Why?
Severity of Illness Index
4
2006
423
0.080
Why?
Orgasm
1
1991
7
0.080
Why?
Patient Selection
1
2011
111
0.080
Why?
Social Adjustment
1
2010
11
0.080
Why?
Duloxetine Hydrochloride
2
2015
3
0.080
Why?
Rhabdomyolysis
1
2010
5
0.080
Why?
Follow-Up Studies
4
2015
726
0.080
Why?
Sleep Initiation and Maintenance Disorders
2
2000
45
0.070
Why?
Ambulatory Care
3
2003
36
0.070
Why?
Nausea
2
1999
16
0.070
Why?
Sleep Stages
2
1999
12
0.070
Why?
Ribavirin
1
2007
3
0.060
Why?
Interferon-alpha
1
2007
15
0.060
Why?
Antiviral Agents
1
2007
27
0.060
Why?
Half-Life
2
1997
7
0.060
Why?
Hepatitis C, Chronic
1
2007
18
0.060
Why?
Syndrome
2
1997
40
0.060
Why?
Adrenergic Uptake Inhibitors
2
2004
5
0.060
Why?
Substance-Related Disorders
1
2007
58
0.060
Why?
Hypericum
1
2005
1
0.060
Why?
Phytotherapy
1
2005
8
0.060
Why?
Electric Stimulation Therapy
1
2005
18
0.060
Why?
Thiophenes
1
2004
7
0.050
Why?
Comorbidity
3
2002
209
0.050
Why?
Morpholines
1
2003
7
0.050
Why?
Chronic Disease
2
2002
186
0.050
Why?
Paroxetine
2
2007
7
0.050
Why?
Patient Care Planning
1
2003
15
0.050
Why?
Weight Gain
2
2000
30
0.050
Why?
Practice Guidelines as Topic
1
2002
116
0.040
Why?
Thiazoles
1
2001
8
0.040
Why?
Psychomotor Agitation
1
2001
5
0.040
Why?
Health Status
2
2003
96
0.040
Why?
Telephone
1
2000
12
0.040
Why?
Psychotic Disorders
1
2001
20
0.040
Why?
Psychometrics
1
2000
95
0.040
Why?
Asthenia
1
2000
1
0.040
Why?
Desipramine
1
2000
1
0.040
Why?
Feeding and Eating Disorders
1
2000
6
0.040
Why?
Sensitivity and Specificity
1
2000
252
0.040
Why?
Behavior Therapy
1
2000
46
0.040
Why?
Reproducibility of Results
1
2000
324
0.040
Why?
Attitude to Health
1
2000
55
0.040
Why?
Body Weight
1
1999
72
0.040
Why?
Headache
1
1999
22
0.040
Why?
Delayed-Action Preparations
2
2010
18
0.040
Why?
Anxiety
1
1999
73
0.040
Why?
Abbreviations as Topic
1
1997
1
0.030
Why?
Paresthesia
1
1997
2
0.030
Why?
Treatment Refusal
1
1997
8
0.030
Why?
Receptors, Serotonin
1
1997
10
0.030
Why?
Neurotransmitter Agents
1
1997
7
0.030
Why?
Medical History Taking
1
1997
11
0.030
Why?
Life Change Events
1
1997
21
0.030
Why?
Norepinephrine
1
1997
19
0.030
Why?
Dizziness
1
1997
9
0.030
Why?
Medical Records
1
1997
13
0.030
Why?
Down-Regulation
1
1997
46
0.030
Why?
Primary Health Care
1
1997
35
0.030
Why?
Drug Resistance
2
2006
20
0.030
Why?
Incidence
1
1997
338
0.030
Why?
Genotype
1
2014
169
0.030
Why?
Risk Factors
1
1997
1049
0.020
Why?
Benzodiazepines
2
2003
21
0.020
Why?
Neuropsychological Tests
1
2015
558
0.020
Why?
Biomarkers
1
2014
294
0.020
Why?
Chemotherapy, Adjuvant
1
2012
40
0.020
Why?
Serotonin Antagonists
1
1991
2
0.020
Why?
Drug Interactions
1
1991
16
0.020
Why?
Iatrogenic Disease
1
1991
13
0.020
Why?
Drugs, Investigational
1
1990
3
0.020
Why?
Longitudinal Studies
1
2010
651
0.020
Why?
Outpatients
1
2007
24
0.020
Why?
Chi-Square Distribution
1
2006
60
0.020
Why?
Stress, Psychological
1
2007
112
0.010
Why?
Endpoint Determination
1
2005
12
0.010
Why?
Plant Extracts
1
2005
6
0.010
Why?
Mood Disorders
1
2005
13
0.010
Why?
Analysis of Variance
1
2005
125
0.010
Why?
Reference Values
1
2005
103
0.010
Why?
Case-Control Studies
1
2005
256
0.010
Why?
Survival Analysis
1
2003
99
0.010
Why?
Health Services
1
2003
4
0.010
Why?
Health Care Costs
1
2003
32
0.010
Why?
Patient Satisfaction
1
2003
118
0.010
Why?
Injections, Intramuscular
1
2001
6
0.010
Why?
Schizophrenic Psychology
1
2001
11
0.010
Why?
Area Under Curve
1
2001
39
0.010
Why?
Schizophrenia
1
2001
27
0.010
Why?
Appetite
1
1999
3
0.010
Why?
Weight Loss
1
1999
78
0.010
Why?
Body Mass Index
1
1999
221
0.010
Why?
Zajecka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (159)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_